Capital International’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Capital International's VRTX Position: Q3 2026 in Review
Capital International increased its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q3 2026, buying an estimated $1.39M and bringing the position to 100,051 shares worth $52.3M. The position accounts for 1.68% of the portfolio, ranked #15.
Capital International first reported a position in VRTX in Q1 2018 and has held it in 29 quarters since. The position peaked at $56.8M in Q2 2025. 1,772 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Capital International held 100,051 shares of Vertex Pharmaceuticals worth $52.3M as of Q3 2026.
- Capital International bought 2,717 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.39M.
- Vertex Pharmaceuticals made up 1.68% of Capital International's portfolio in Q3 2026, its #15 holding.
- Capital International first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 29 quarters since.
- Capital International's Vertex Pharmaceuticals position peaked at $56.8M in Q2 2025.
- 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Capital International's 13F filing for Q3 2026, filed 12 Nov 2026.